Company

Basking Biosciences Inc

Biotechnology Columbus, Oh, United States 11 employees

Employees: 11
Contacts: 4
Emails: 4
Phones: 2

www.baskingbiosciences.com LinkedIn Crunchbase

Basking Biosciences Inc Overview

Headquarters: Columbus, Oh, United States
Website: www.baskingbiosciences.com
Industry: Biotechnology
Employees: 11
Founded: 2019
Funding: 55.0M

Keywords

pharma neurology biotech cardiovascular

About Basking Biosciences Inc

Basking Biosciences is developing a novel first-line therapy (BB-031) targeting von Willebrand Factor (vWF), along with a direct acting reversal agent (BB-025) to immediately neutralize the pharmacological effect of BB-031 in the event of bleeding. BB-031 is an RNA aptamer optimized for rapid onset of action and short duration of effect. BB-031 is being evaluated in patients with acute ischemic stroke (AIS) in the RAISE trial, a two-part Phase 2 study assessing the safety and preliminary efficacy of the investigational drug candidate. The technology is based on two decades of translational research on RNA aptamers as therapeutic agents for cardiovascular diseases.

Basking Biosciences Inc Contact Details

People in AeroLeads: 4
With contact data: 4
Email contacts: 4; 100.0% coverage
Phone contacts: 2; 50.0% coverage

Basking Biosciences Inc Org Chart

Sample employees and titles

Name	Title	Location	Contact
Holly Eden Zahn		Raleigh, North Carolina, United States	Email
Rob Hughes	Fractional CFO, Mba and Cpa	Durham, North Carolina, United States	Email Phone
Tom Needham	Biotech Vc Investor - Broadview Ventures - Longview Ventures	Greater Boston, United States	Email Phone
Stacy Hammonds Nelson	VP, Global Drug Development	Durham, North Carolina, United States	Email